Allopurinol-induced DRESS syndrome in an adolescent patient

Pediatric Dermatology

Volumn 27, Issue 3, 2010, Pages 270-273

  Dewan, Ashvin K ^a   Quinonez, Ricardo A ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; METHYLPREDNISOLONE; AMINOTRANSFERASE; ANTIGOUT AGENT;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DIAGNOSTIC TEST; DRESS SYNDROME; EMERGENCY WARD; EOSINOPHILIA; ESSENTIAL HYPERTENSION; FEVER; HUMAN; HYPERTRANSAMINASEMIA; LABORATORY TEST; LEUKOCYTOSIS; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SYMPTOMATOLOGY; BLOOD; CHEMICALLY INDUCED; DRUG ERUPTIONS; HYPERTENSION; SYNDROME;

ADOLESCENT; ALLOPURINOL; DRUG ERUPTIONS; EOSINOPHILIA; FEVER; GOUT SUPPRESSANTS; HUMANS; HYPERTENSION; LEUKOCYTOSIS; MALE; METHYLPREDNISOLONE; SYNDROME; TRANSAMINASES;

EID: 77952767660     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2009.00983.x     Document Type: Article

References (25)

1. Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthritis Rheum 1986 29 : 82 87.
2. McInnes GT, Lawson DH, Jick H. Acute adverse reactions attributed to allopurinol in hospitalized patients. Ann Rheum Dis 1981 40 : 245 249.
3. Arellano F, Sacristan JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993 27 : 337 343.
4. Lang PG Jr. Severe hypersensitivity reactions to allopurinol. South Med J 1979 72 : 1361 1368.
5. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology, 2003 206 : 353 356.
6. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996 15 : 250 257.
7. Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003 4 : 561 572. (Pubitemid 36995078)
8. Elasy T, Kaminsky D, Tracy M, Mehler PS. Allopurinol hypersensitivity syndrome revisited. West J Med 1995 162 : 360 361.
9. Sommers LM, Schoene RB. Allopurinol hypersensitivity syndrome associated with pancreatic exocrine abnormalities and new-onset diabetes mellitus. Arch Intern Med 2002 162 : 1190 1192.
10. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001 137 : 357 364.
11. Wolf R, Orion E, Marcos B, Matz H. Life-threatening acute adverse cutaneous drug reactions. Clin Dermatol 2005 23 : 171 181.
12. Pluim HJ, van Deuren M, Wetzels JF. The allopurinol hypersensitivity syndrome. Neth J Med 1998 52 : 107 110.
13. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994 331 : 1272 1285.
14. Baba M, Aksungur VL, Homan S, Yücel A, Acar MA, Memişoglu HR. The anticonvulsant hypersensitivity syndrome. J Eur Acad Dermatol Venereol 2003 17 : 399 401.
15. Green VJ, Pirmohamed M, Kitteringham NR, Gaedigk A, Grant DM, Boxer M, Burchell B, Park BK. Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. Biochem Pharmacol 1995 50 : 1353 1359.
16. Scheuerman O, Nofech-Moses Y, Rachmel A, Ashkenazi S. Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin. Pediatrics 2001 107 : E14.
17. Attarian HP, Berg MJ, McBride MC, Erickson SM, Erba G. Allergies to multiple antiseizure medications: a relationship to ANA and SSA. Neurology 1999 53 : 434 435.
18. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988 82 : 1826 1832.
19. Knowles SR, Shapiro LE, Shear NH. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 1999 21 : 489 501.
20. Hicks RA, Murphy JV, Jackson MA. Kawasaki-like syndrome caused by carbamazepine. Pediatr Infect Dis J 1988 7 : 525 526.
21. Sarris BM, Wong JG. Multisystem hypersensitivity reaction to lamotrigine. Neurology 1999 53 : 1367.
22. Sontheimer RD, Houpt KR. DIDMOHS: A Proposed Consensus Nomenclature for the Drug-Induced Delayed Multiorgan Hypersensitivity Syndrome 1998 : 874 876.
23. Callot V, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol 1996 132 : 1315 1321.
24. Chopra S, Levell NJ, Cowley G, Gilkes JJ. Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Br J Dermatol 1996 134 : 1109 1112.
25. Roujeau JC. Treatment of severe drug eruptions. J Dermatol 1999 26 : 718 722.